Citation Impact
Citing Papers
SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
2011
Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic Carcinoma
2011
Metastasis: from dissemination to organ-specific colonization
2009 Standout
AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
2007 StandoutNobel
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
2010
Current knowledge on exosome biogenesis and release
2017 Standout
The heparanase/syndecan‐1 axis in cancer: mechanisms and therapies
2013
Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase
2005 StandoutNobel
Heparan sulfate proteoglycans and cancer
2001
Heparin-Protein Interactions
2002 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions
2015
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
2000
Hepatocellular carcinoma
2018 Standout
Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry
2001
Cancer to bone: a fatal attraction
2011 Standout
Glycosaminoglycans: key players in cancer cell biology and treatment
2012
Syndecans: proteoglycan regulators of cell-surface microdomains?
2003
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
2009
Proteoglycans: Master modulators of paracrine fibroblast–carcinoma cell interactions
2009
The ClusPro web server for protein–protein docking
2017 Standout
Significance of Heparanase in Cancer and Inflammation
2011
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Pericytes: gatekeepers in tumour cell metastasis?
2007
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
2008
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
2015
Heparan sulfate proteoglycans in invasion and metastasis
2001
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
2010
Biological roles of glycans
2016 Standout
Putting tumours in context
2001 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Extracellular matrix structure
2015 Standout
Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme
2014
Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
2008
Immunohistochemical Expression Patterns of Germinal Center and Activation B-cell Markers Correlate With Prognosis in Diffuse Large B-cell Lymphoma
2004
Remodelling the extracellular matrix in development and disease
2014 Standout
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
2006
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice
2011
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
2007
GlcNAc 2-Epimerase Can Serve a Catabolic Role in Sialic Acid Metabolism
2003 StandoutNobel
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Microenvironmental regulation of metastasis
2008 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine
2015
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
2010
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Metastasis: the seed and soil theory gains identity
2007
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Monoclonal antibodies in myeloma.
2015
The Fibroblast Growth Factor signaling pathway
2015 Standout
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Exosomes
2019 Standout
Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis
2010
gp340 Promotes Transcytosis of Human Immunodeficiency Virus Type 1 in Genital Tract-Derived Cell Lines and Primary Endocervical Tissue
2009 StandoutNobel
Genes Associated With Breast Cancer Metastatic to Bone
2006
Transmembrane Signaling Proteoglycans
2010
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
2011
The extracellular matrix at a glance
2010 Standout
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins
2000
High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review
2011 Standout
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
2010
Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
2005
Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis
2007
Recent Advances in the Prevention of Hepatocellular Carcinoma Recurrence
2014
Complexity within the plasma cell compartment of mice deficient in both E- and P-selectin: implications for plasma cell differentiation
2003
Kinetic Analysis of NodST Sulfotransferase Using an Electrospray Ionization Mass Spectrometry Assay
2002 StandoutNobel
Advances in biology of multiple myeloma: clinical applications
2004
Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma
2002
Multiple Myeloma
2011 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Regulatory Principles of Developmental Signaling
2002 StandoutNobel
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
GLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
2006
Proteoglycans and their roles in brain cancer
2013
Syntenin and syndecan in the biogenesis of exosomes
2015
Works of Allison Theus being referenced
Heparanase Enhances Syndecan-1 Shedding
2007
Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies
2005
Elevated levels of shed syndecan‐1 correlate with tumour mass and decreased matrix metalloproteinase‐9 activity in the serum of patients with multiple myeloma
1997
Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.
2002
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
2002
Heparanase promotes the spontaneous metastasis of myeloma cells to bone
2004
Syndecan-1 Is a Multifunctional Regulator of Myeloma Pathobiology: Control of Tumor Cell Survival, Growth, and Bone Cell Differentiation
1998